Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer
Open accessAbstract
Small cell lung cancer (SCLC) is an aggressive disease characterized by rapid growth and metastases. It has been recognized that the inflammation of the microenvironment plays a critical role in the development of malignancies. However, little is known about the role of multiple inflammatory and hematological markers in the prognosis of SCLC. The aim of this study was to determine the clinical significance of pre-treatment inflammation-based scores and characteristics as prognostic indicators for the survival of SCLC patients. A retrospective analysis of 919 SCLC cases was performed. Patients' characteristics and hematologic tests data at initial diagnosis were collected. The univariate analysis of all SCLC patients indicated that favorable prognostic factors were age ˂ 70 years, non-smokers, good performance status, limited disease and response to treatment. Moreover, univariate analysis of inflammation-based scores and other blood parameters showed that neutrophil-lymphocyte ratio ≥ 5, platelet-lymphocyte ratio ≥ 250, systemic immune-inflammation index (SII) ≥ 1,600 × 10(9)/L, prognostic nutritional index (albumin + 5 × lymphocyte) < 45, and elevated serum lactate dehydrogenase (LDH) predicted poor prognosis in SCLC patients. SII represents the score that is calculated as follows: platelet count × neutrophil count/lymphocyte count. In the multivariate analysis, SII, together with serum LDH, stage and response to therapy, were associated with overall survival (OS). This study demonstrated that the combination of platelet count and neutrophil-lymphocyte ratio could help to predict poor prognosis in SCLC. Our findings will facilitate the understanding of survival differences in SCLC patients in clinical practice.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · see citing works
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261 · see citing works
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · see citing works
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761 · see citing works
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493 · see citing works
Noda, K., Nishiwaki, Y., Kawahara, M., Negoro, S., Sugiura, T., Yokoyama, A., Fukuoka, M., Mori, K., Watanabe, K., Tamura, T., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa003034 · Cited by 1,370 · see citing works
Systemic inflammation, nutritional status and survival in patients with cancer
McMillan, D. C. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832a7902 · Cited by 1,006 · see citing works
Proctor, M. J., Morrison, D. S., Talwar, D. K., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 759 · see citing works
Albain, K. S., Crowley, J. J., LeBlanc, M. L., & Livingston, R. B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1618 · Cited by 729 · see citing works
Takada, M., Fukuoka, M., Kawahara, M., Sugiura, T., Yokoyama, A., Yokota, S., Nishiwaki, Y., Watanabe, K., Noda, K., Tamura, T., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.071 · Cited by 705 · see citing works
Roth, B. J., Johnson, D. H., Einhorn, L. H., Schacter, L., Cherng, N. C., Cohen, H. J., Crawford, J., Randolph, J., Goodlow, J. L., & Broun, G. O. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.282 · Cited by 555 · see citing works
Pinato, D. J., North, B. V., & Sharma, R. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.92 · Cited by 424 · see citing works
Albain, K. S., Crowley, J. J., LeBlanc, M. L., et al. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.9.1563 · Cited by 386 · see citing works
VP-16 and cisplatin as first-line therapy for small-cell lung cancer.
Evans, W. K., Shepherd, F. A., Feld, R. D., et al. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.11.1471 · Cited by 318 · see citing works
Paramanathan, A., Saxena, A., & Morris, D. L. (2013) · Surgical Oncology · doi:10.1016/j.suronc.2013.12.001 · Cited by 316 · see citing works
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Fushiya, N., Koike, K., Nishino, H., & Tajiri, H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.354 · Cited by 294 · see citing works
Lee, S., Oh, S. Y., Kim, S. H., Lee, J. H., Kim, M. C., Kim, K. H., & Kim, H. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-350 · Cited by 282 · see citing works
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
Kang, M. H., Go, S.-I., Song, H.-N., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.317 · Cited by 200 · see citing works
Liu, X., Meng, Q. H., Ye, Y., Hildebrandt, M. A. T., Gu, J. H., & Wu, X. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu247 · Cited by 188 · see citing works
Bremnes, R. M., Sundstrøm, S. H., Aasebø, U., Kaasa, S., Hatlevoll, R., & Aamdal, S. (2003) · Lung Cancer · doi:10.1016/s0169-5002(02)00508-1 · Cited by 186 · see citing works
Prognostic factors differ by tumor stage for small cell lung cancer
Foster, N. R., Mandrekar, S. J., Schild, S. E., Nelson, G. D., Rowland, K. M., Deming, R. L., Kozelsky, T. F., Marks, R. S., Jett, J. R., & Adjei, A. A. (2009) · Cancer · doi:10.1002/cncr.24314 · Cited by 128 · see citing works
Impact of Pretreatment Body Mass Index on Patients With Head-and-Neck Cancer Treated With Radiation
Pai, P., Chuang, C., Tseng, C., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.11.071 · Cited by 94 · see citing works
Socinski, M. A., Weissman, C., Hart, L. L., Beck, J. T., Choksi, J. K., Hanson, J. P., Prager, D., Monberg, M., Ye, Z., & Obasaju, C. K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.7016 · Cited by 82 · see citing works
Hermes, A., Gatzemeier, U., Waschki, B., et al. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.07.013 · Cited by 74 · see citing works
Sun, J.-M., Choi, Y.-L., Ji, J. H., Ahn, J. S., Kim, K.-M., Han, J., Ahn, M.-J., & Park, K. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu504 · Cited by 68 · see citing works
Weide, B., Richter, S., Buttner, P. G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081624 · Cited by 65 · see citing works
Taş, F., Aydıner, A., Demir, C., et al. (2001) · American Journal of Clinical Oncology · doi:10.1097/00000421-200108000-00013 · Cited by 63 · see citing works
Pathology of small cell carcinoma of the lung
Zakowski, M. F. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50015 · Cited by 60 · see citing works
Prognostic Significance of Pretreatment Laboratory Parameters in Combined Small-Cell Lung Cancer
Wang, X., Jiang, R., & Li, K. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9845-3 · Cited by 57 · see citing works
Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer
Philipp, A. B., Nagel, D., Stieber, P., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-245 · Cited by 53 · see citing works
Small Cell Lung Cancer: Are We Making Progress?
Dowell, J. E., & Palmer, B. F. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181bccef5 · Cited by 51 · see citing works
Zhou, T., Hong, S., Hu, Z., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2623-4 · Cited by 49 · see citing works
A Laboratory Prognostic Index Model for Patients with Advanced Non-Small Cell Lung Cancer
Ulaş, A., Türköz, F. P., Sılay, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114471 · Cited by 48 · see citing works
Qu, X. H., Zhang, T., Ma, H., et al. (2014) · Future Oncology · doi:10.2217/fon.14.121 · Cited by 45 · see citing works
Pinato, D. J., Stavraka, C., Flynn, M. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083279 · Cited by 34 · see citing works
Dellapasqua, S., Bagnardi, V., Bertolini, F., et al. (2012) · The Breast · doi:10.1016/j.breast.2012.01.015 · Cited by 29 · see citing works
Body Mass Index, Weight Change, and Survival in Non-Hodgkin Lymphoma Patients in Connecticut Women
Han, X., Stevens, J., & Bradshaw, P. T. (2013) · Nutrition and Cancer · doi:10.1080/01635581.2013.741760 · Cited by 21 · see citing works
Çetin, B., Afşar, B., Değer, S. M., et al. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0613-x · Cited by 21 · see citing works
Mixed mesodermal tumor and clear cell carcinoma arising in ovarian endometriosis
Cooper, P. (1978) · Cancer · doi:10.1002/1097-0142(197812)42:6 · Cited by 21 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer
Huang, H., Liu, Q., Zhu, L., Zhang, Y., Lu, X., Wu, Y., & Liu, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39150-0 · Cited by 408 · see citing works
Geng, Y., Shao, Y., Zhu, D., Zheng, X., Zhou, Q., Zhou, W., Ni, X., Wu, C., & Jiang, J. (2016) · Scientific Reports · doi:10.1038/srep39482 · Cited by 233 · see citing works
Dadouli, K., Janho, M. B., Hatziefthimiou, A., Voulgaridi, I., Piaha, K., Anagnostopoulos, L., Ntellas, P., Mouchtouri, V. A., Bonotis, K., Christodoulou, N., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12081034 · Cited by 57 · see citing works
Tzikos, G., Alexiou, I., Tsagkaropoulos, S., Menni, A.-E., Chatziantoniou, G., Doutsini, S., Papavramidis, T., Grosomanidis, V., Stavrou, G., & Kotzampassi, K. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030473 · Cited by 28 · see citing works
Hu, Y., Yao, Y., Xie, Y., Liu, Q., He, H., Li, Z., Chen, M., & Zhu, L. (2024) · BMC Oral Health · doi:10.1186/s12903-024-05335-x · Cited by 5 · see citing works
Agüloğlu, N., Akyol, M., Kömek, H., & Katgı, N. (2022) · Molecular Imaging and Radionuclide Therapy · doi:10.4274/mirt.galenos.2022.24650 · Cited by 4 · see citing works
- Authors
- Hong, X., Cui, B., Wang, M., Yang, Z., Wang, L., & Xu, Q.
- Affiliations
- Third Affiliated Hospital of Harbin Medical University (CN)
- Venue
- The Tohoku Journal of Experimental Medicine
- Publisher
- Tohoku University Medical Press
- Published
- 2015
- Volume
- 236
- Issue
- 4
- Pages
- 297-304
- ISSN
- 0040-8727 (ISSN-L)
- 1349-3329
- OpenAlex
- W1795565596
- Cited by
- 326
- References
- 39
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 38 · 2023: 32 · 2022: 40 · 2021: 46 · 2020: 43 · 2019: 32 · 2018: 27 · 2017: 19 · 2016: 8 · 2015: 1
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- The Tohoku Journal of Experimental Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Keywords
- small cell lung cancer, systemic immune-inflammation index, platelet count, neutrophil-to-lymphocyte ratio, prognostic factors, overall survival, lactate dehydrogenase, prognostic nutritional index, tumor microenvironment inflammation
- MeSH terms
- Age Factors, Humans, L-Lactate Dehydrogenase, Leukocytes, Neutrophils, Platelet Count, Prognosis, Severity of Illness Index, Smoking, Survival Analysis, Small Cell Lung Carcinoma, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
